Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
395.00
+1.00 (0.25%)
Sep 8, 2026, 11:49 AM CST

Sunmax Biotechnology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,1952,0261,8181,6891,4001,036
Revenue Growth
12.50%11.45%7.64%20.64%35.19%21.01%
Gross Profit
1,7361,5891,4791,4051,193894.45
Operating Income
1,094998.31926.96894.8768367.37
Net Income
811.53725.75679.41625.71533.83245.64
Earnings Per Share
14.8813.3112.4611.479.794.51
EPS Growth
16.07%6.82%8.63%17.16%117.07%3.20%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Taiwan Operating Segment
1,1971,049949.18768.19608.38456.86
Mainland China Consolidation Department
1,9271,8081,6651,5341,258929.39
Adjustments and Eliminations
-928.96-830.31-795.73-613.54-465.91-350.59
Total
2,1952,0261,8181,6891,4001,036

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
793.19961.59865.47961.79816.67679.34
Total Debt
108.37119.33145.21169.0263.0999.18
Net Cash (Debt)
684.82842.26720.26792.78753.58580.16
Net Cash Growth
-37.11%16.94%-9.15%5.20%29.89%-25.59%
Net Cash Per Share
12.5515.4413.2114.5413.8210.64

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
959.28825.92561.04848.56644.57243.28
Capital Expenditures
-88.81-59.61-31.97-107.66-154.58-253.02
Free Cash Flow
870.47766.31529.07740.9489.99-9.74
Free Cash Flow Growth
19.97%44.84%-28.59%51.21%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
79.07%78.41%81.33%83.18%85.19%86.37%
Operating Margin
49.82%49.27%50.99%52.98%54.85%35.47%
Pretax Margin
51.01%50.07%52.44%53.84%55.51%34.52%
Profit Margin
36.97%35.82%37.37%37.05%38.13%23.72%
FCF Margin
39.66%37.82%29.10%43.87%35.00%-0.94%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
12.10012.10011.60011.0009.5004.400
Dividend Per Share Growth
0%4.31%5.46%15.79%115.91%120.00%
Dividend Yield
2.99%3.15%4.40%5.93%8.01%6.33%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
26.4829.7222.4517.7613.8818.31
P/FCF Ratio
24.6528.1428.8215.0015.12-
PS Ratio
9.7810.648.396.585.294.34